Early azathioprine in crohn's disease

Inflammatory Bowel Diseases

Volumn 19, Issue 3, 2013, Pages 674-675

  Cosnes, Jacques ^a   Seksik, Philippe ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BIOLOGICAL PRODUCT; IMMUNOMODULATING AGENT; TUMOR NECROSIS FACTOR INHIBITOR;

CLINICAL ASSESSMENT TOOL; CROHN DISEASE; DISEASE SEVERITY; DRUG EFFICACY; HAZARD RATIO; HUMAN; INCIDENCE; NOTE; PRESCRIPTION; PRIORITY JOURNAL; PROPENSITY SCORE; REIMBURSEMENT; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 84876366594     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e318281d697     Document Type: Note

References (7)

1. Wolters FL, Russel MG, Stockbrugger RW. Systematic review: has disease outcome in Crohn's disease changed during the last four decades? Aliment Pharmacol Ther. 2004;20:483-496.
2. Etchevers MJ, Aceituno M, Sans M. Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease. World J Gastroenterol. 2008;14:5512-5518.
3. Ramadas AV, Gunesh S, Thomas GA, et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut. 2010;59: 1200-1206.
4. Sans M, Lopez-San Roman A, Esteve M, et al. Early use of azathioprine has a steroid sparing effect on recently diagnosed Crohn's disease patients. Gastroenterology. 2011;140:S109.
5. Cosnes J, Bourrier A, Laharie D, et al. Accelerated step-care therapy with early azathioprine (AZA) vs conventional step-care therapy in Crohn's disease. A randomized study. Gastroenterology. 2012; 142.
6. Peyrin-Biroulet L, Oussalah A, Williet N, et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease. Gut. 2011;60:930-936.
7. Colombel JF, Rutgeerts P, Reinisch W, et al. SONIC: a randomized doubleblind controlled trial comparing Infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy. Gut. 2008;57:A1.